0000911916-17-000028.txt : 20170104
0000911916-17-000028.hdr.sgml : 20170104
20170104162534
ACCESSION NUMBER: 0000911916-17-000028
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170103
FILED AS OF DATE: 20170104
DATE AS OF CHANGE: 20170104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CoLucid Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001348649
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 203419541
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 222 THIRD STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 781-365-2596
MAIL ADDRESS:
STREET 1: 222 THIRD STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Colucid Pharmaceuticals Inc
DATE OF NAME CHANGE: 20060104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kuca Bernice
CENTRAL INDEX KEY: 0001639976
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37358
FILM NUMBER: 17505828
MAIL ADDRESS:
STREET 1: 15 NEW ENGLAND EXECUTIVE PARK
CITY: BURLINGTON
STATE: MA
ZIP: 01803
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2017-01-03
0001348649
CoLucid Pharmaceuticals, Inc.
CLCD
0001639976
Kuca Bernice
C/O COLUCID PHARMACEUTICALS, INC.
222 THIRD STREET
CAMBRIDGE
MA
02142
0
1
0
0
Head,Clin. and Reg. Operations
Common Stock
2017-01-03
4
S
0
772
36.25
D
40086
D
Securities sold pursuant to a written plan intended to comply with Rule 10b5-1(c)(i) adopted by Ms. Kuca on August 15, 2016. One purpose of the plan is to sell shares of common stock acquired under the CoLucid Pharmaceuticals, Inc. Employee Stock Purchase Plan.
/s/ Christine G. Long, Attorney-in-Fact for Bernice Kuca (power of attorney previously filed)
2017-01-04